First, MKLN1-AS can increase the expression of hepatocellular carcinoma-derived growth factors, which compete with miR-654-3p for endogenous RNAs and promote HCC progression through the MKLN1-AS/hepatic-derived growth factor pathway [94]. This evidence concerns the gene MKLN1 and hepatocellular carcinoma.